Organ preservation via immunotherapy-based total neoadjuvant therapy in early low rectal cancer (TORCH-E): a multicenter, open-label, single-arm, phase 2 study.

已完结 20 由达姆发布于 2026/6/8 9:31:31

DOI:10.1158/1078-0432.ccr-25-0975
作者：Fan Xia,Yajie Chen,Di Zhou,Juefeng Wan,Lijun Shen,Yaqi Wang,JinLuan Li,Hui Zhang,Yan Wang,Wang Yang,Menglong Zhou,Ruiyan Wu,Shujuan Zhou,Yikuan Chen,Dakui Luo,Wenchao Gu,Peng Lian,Junjie Peng,Fangqi L
文献类型：期刊论文
补充材料：只需要正文

American Association for Cancer Research (AACR)

Abstract：PURPOSE Organ preservation (OP) can be preferred in low-lying rectal cancer to reduce morbidity from radical surgery. Immunotherapy-based total neoadjuvant therapy (iTNT) showed remarkable

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierPOM-incorporated ZnIn2S4 Z-scheme dual-functional photocatalysts for cooperative benzyl alcohol oxidation and H2 evolution in aqueous solution